$6.56
0.050.77%
最終更新: Oct 22, 10:07 AM
$6.40
-0.11-1.69%
Benzinga
Benzinga
Benzinga
木曜日, 10 22
Benzinga
© 2026 Benzinga | All Rights Reserved
Achieve Life Sciences (ACHV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.16 | $-0.30 | $-0.27 | $-0.25 |
| Actual | $-0.80 | $-0.19 | $-0.28 | $-0.28 |
| Surprise | -400.0% | +36.7% | -3.70% | -12.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.19 | $-0.21 | $-0.17 | $-0.14 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.80 | $-0.16 | -400.0 % |
| Q1 | May 12, 2026 | $-0.19 | $-0.30 | 36.7 % |
| Q4 | Mar 24, 2026 | $-0.28 | $-0.27 | -3.70 % |
| Q3 | Nov 6, 2025 | $-0.28 | $-0.25 | -12.0 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Mar 16, 2023 | $0 | $100.00K | -100.0 % |
| Q3 | Nov 14, 2022 | $0 | $40.00K | -100.0 % |
| Q2 | Aug 11, 2022 | $0 | $40.00K | -100.0 % |
| Q4 | Mar 10, 2022 | $0 | $40.00K | -100.0 % |